Literature DB >> 8073628

Bovine tuberculosis in Latin America and the Caribbean: current status, control and eradication programs.

I N de Kantor1, V Ritacco.   

Abstract

Out of the approximately 300 million head which constitute the bovine population in Latin America and the Caribbean, 80 million are found in countries where rates of Mycobacterium bovis infection are very low or nil. The remaining 220 million are found in countries with either a moderate to high prevalence or where no recent information is available. Argentina and Brazil, both have huge cattle populations with estimated prevalences higher than 1%, and together may harbour 3.5 million infected cattle. Information on the impact of M. bovis on human health in the Region is scarce and does not include data on infection of children. In Argentina, human tuberculosis of bovine origin was found to be mainly an occupational disease, transmitted by aerosol. Control or eradication has been achieved in several countries in the Region by use of the tuberculin test followed by sacrifice of reactors. In countries such as Cuba, where the prevalence is already very low, area tuberculin testing is being replaced by slaughter surveillance and epidemiological trace-back. Other countries, where the prevalence is high (e.g. Chile, Paraguay, Peru and Argentina), promote regional campaigns based on the decision and active participation of cattle farmers. Recent diagnostic developments based on the in vitro measurement of humoral and cellular immune responses could be an aid in control and eradication campaigns, provided their usefulness is demonstrated in field trials. In heavily infected areas complementary or alternative strategies should also be proposed, aiming at lowering the prevalence rates prior to the application of the test and slaughter method.

Entities:  

Mesh:

Year:  1994        PMID: 8073628     DOI: 10.1016/0378-1135(94)90042-6

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Sequence analysis of the direct repeat region in Mycobacterium bovis.

Authors:  K Caimi; M I Romano; A Alito; M Zumarraga; F Bigi; A Cataldi
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Amplification of a 500-base-pair fragment from cultured isolates of Mycobacterium bovis.

Authors:  J G Rodríguez; J C Fissanoti; P Del Portillo; M E Patarroyo; M I Romano; A Cataldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

3.  Towards elimination of tuberculosis in a low income country: the experience of Cuba, 1962-97.

Authors:  A Marrero; J A Caminero; R Rodríguez; N E Billo
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 4.  Zoonotic tuberculosis due to Mycobacterium bovis in developing countries.

Authors:  O Cosivi; J M Grange; C J Daborn; M C Raviglione; T Fujikura; D Cousins; R A Robinson; H F Huchzermeyer; I de Kantor; F X Meslin
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

5.  Usefulness of spoligotyping in molecular epidemiology of Mycobacterium bovis-related infections in South America.

Authors:  M J Zumárraga; C Martin; S Samper; A Alito; O Latini; F Bigi; E Roxo; M E Cicuta; F Errico; M C Ramos; A Cataldi; D van Soolingen; M I Romano
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 6.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

7.  Prevalence and risk factors for bovine tuberculosis in Minas Gerais State, Brazil.

Authors:  Ana Paula Cunha Belchior; Luciano Bastos Lopes; Vitor Salvador Picão Gonçalves; Rômulo Cerqueira Leite
Journal:  Trop Anim Health Prod       Date:  2015-11-19       Impact factor: 1.559

8.  Comparison of three decontamination methods for Mycobacterium bovis isolation.

Authors:  Simone Rodrigues Ambrosio; Eugenia Márcia de Deus Oliveira; Cesar Alejandro Rosales Rodriguez; José Soares Ferreira Neto; Marcos Amaku
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.